Literature DB >> 20711224

Purinergic signaling: a novel mechanism in immune surveillance.

Lin Mei1, Wei Du, Wei Gao, Qi-bing Mei.   

Abstract

Purinergic receptors and the associated signaling cascades are known to play critical roles in cardiovascular, nervous, respiratory, gastrointestinal and urinogenital systems. Recent studies have also shed light on the importance of nucleotides and purinergic receptors in the regulation of the immune response. With a better understanding of the distribution and the receptor subtypes, the purinoceptors have the potential to become important therapeutic targets in inflammation, chemotaxis and immune-related diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711224      PMCID: PMC4002306          DOI: 10.1038/aps.2010.128

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  40 in total

1.  P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease.

Authors:  Lav K Parvathenani; Svetlana Tertyshnikova; Corinne R Greco; Susan B Roberts; Barbara Robertson; Rand Posmantur
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

2.  P2X7 receptor inhibition improves recovery after spinal cord injury.

Authors:  Xiaohai Wang; Gregory Arcuino; Takahiro Takano; Jane Lin; Wei Guo Peng; Pinglan Wan; Pingjia Li; Qiwu Xu; Qing Song Liu; Steven A Goldman; Maiken Nedergaard
Journal:  Nat Med       Date:  2004-07-18       Impact factor: 53.440

Review 3.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

4.  A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells.

Authors:  Ross Corriden; Paul A Insel; Wolfgang G Junger
Journal:  Am J Physiol Cell Physiol       Date:  2007-08-15       Impact factor: 4.249

5.  ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

Authors:  Yu Chen; Ross Corriden; Yoshiaki Inoue; Linda Yip; Naoyuki Hashiguchi; Annelies Zinkernagel; Victor Nizet; Paul A Insel; Wolfgang G Junger
Journal:  Science       Date:  2006-12-15       Impact factor: 47.728

Review 6.  Extracellular nucleotides as negative modulators of immunity.

Authors:  Francesco Di Virgilio; Jean-Marie Boeynaems; Simon C Robson
Journal:  Curr Opin Pharmacol       Date:  2009-07-21       Impact factor: 5.547

Review 7.  Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.

Authors:  Tamás Deli; László Csernoch
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

Review 8.  Purinergic signalling in inflammation of the central nervous system.

Authors:  Francesco Di Virgilio; Stefania Ceruti; Placido Bramanti; Maria P Abbracchio
Journal:  Trends Neurosci       Date:  2009-01-08       Impact factor: 13.837

9.  Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine.

Authors:  Ross Corriden; Yu Chen; Yoshiaki Inoue; Guido Beldi; Simon C Robson; Paul A Insel; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

Review 10.  Liaisons dangereuses: P2X(7) and the inflammasome.

Authors:  Francesco Di Virgilio
Journal:  Trends Pharmacol Sci       Date:  2007-08-10       Impact factor: 14.819

View more
  5 in total

1.  P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.

Authors:  Charline Giroud; Mariana Marin; Jason Hammonds; Paul Spearman; Gregory B Melikyan
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

2.  P2X4 receptor regulates alcohol-induced responses in microglia.

Authors:  Larisa Gofman; Jonathan M Cenna; Raghava Potula
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-20       Impact factor: 4.147

3.  Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing.

Authors:  Edyta Gendaszewska-Darmach; Marta Kucharska
Journal:  Purinergic Signal       Date:  2011-04-26       Impact factor: 3.765

4.  Putative roles of purinergic signaling in human immunodeficiency virus-1 infection.

Authors:  Paulo A F Pacheco; Robson X Faria; Leonardo G B Ferreira; Izabel C N P Paixão
Journal:  Biol Direct       Date:  2014-10-29       Impact factor: 4.540

Review 5.  Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation.

Authors:  Talia H Swartz; George R Dubyak; Benjamin K Chen
Journal:  Front Immunol       Date:  2015-11-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.